Women Deserve Evidence, Not Silence or a Sales Pitch
A patient-centered look at cannabinoids for menstrual pain, sexual health, pregnancy, breastfeeding, and menopause.
Joseph Rosado, MD, MBA, DC
Published September 27, 2026
Society of Cannabis Clinicians / MedCannCon26 — Women’s Health Across the Lifespan
Women are already using cannabis and CBD for menstrual pain, pelvic pain, sleep, anxiety, sexual concerns, and menopause symptoms. Pretending otherwise does not protect them. It leaves them alone with internet claims, product advertising, and inconsistent advice.
Women deserve something better: a clinician willing to listen, explain what the evidence shows, and say clearly when the evidence is not strong enough.
For menstrual and pelvic pain, many women report relief from cannabinoid products. The science offers reasonable explanations for why cannabinoids might influence pain and inflammation. Yet the research is still not strong enough to tell us which product, dose, or route is best. Severe or changing pain still requires a real evaluation. Cannabis should never become a reason to miss endometriosis, fibroids, infection, or another treatable condition.
Sexual health deserves the same honesty. Emerging research suggests that cannabis may help some women relax, become more engaged with sensation, and experience orgasm more easily or intensely. It can also do the opposite. Too much THC may create anxiety, distraction, sedation, dryness, or difficulty reaching orgasm. More is not necessarily better.
Pregnancy is different. Cannabis and CBD have not been established as safe during pregnancy. THC crosses the placenta, and major professional guidance recommends avoiding cannabis during pregnancy. Natural does not automatically mean safe, and CBD is not a proven loophole around that concern.
THC and other cannabinoids can pass into breast milk. A mother who is using cannabis deserves direct, nonjudgmental counseling about infant exposure, avoiding impairment while caring for her child, practical risk reduction, and available support. Shame shuts down honest conversation. It does not reduce risk.
During perimenopause and menopause, women often report using cannabis for sleep, mood, anxiety, and discomfort. Some report real benefit. But cannabis has not been proven to replace established hormonal or nonhormonal treatment, and it should not distract from bone, heart, metabolic, breast, pelvic, and sexual health.
The right question is not, “Is cannabis good or bad for women?” That question is too crude to be useful.
The right questions are: What is the symptom? What is causing it? What else is the patient taking? Is pregnancy possible? What is actually in the product? What benefit are we measuring? What risk would make us stop?
Women should not have to choose between stigma and a sales pitch. They deserve care that is curious but cautious, open-minded but evidence-based, and centered on the patient rather than the product.
Society of Cannabis Clinicians (SCC)
Share this article with patients and healthcare professionals who need honest, evidence-informed counseling rather than stigma or exaggerated claims. Contact Rosado Advisory regarding professional education and cannabinoid clinical strategy.